المؤلفون: Stubberud, Anker, Ingvaldsen, Sigrid Hegna, Brenner, Eiliv, Winnberg, Ingunn, Olsen, Alexander, Gravdahl, Gøril Bruvik, Matharu, Manjit Singh, Nachev, Parashkev, Tronvik, Erling

المساهمون: Funding for Cooperative Projects Between the Department of Neuromedicine and Movement Science and Department of Psychology NTNU Norwegian University of Science and Technology.

المصدر: Cephalalgia ; volume 43, issue 5, page 033310242311692 ; ISSN 0333-1024 1468-2982

مصطلحات موضوعية: Neurology (clinical), General Medicine

الوصف: Introduction Triggers, premonitory symptoms and physiological changes occur in the preictal migraine phase and may be used in models for forecasting attacks. Machine learning is a promising option for such predictive analytics. The objective of this study was to explore the utility of machine learning to forecast migraine attacks based on preictal headache diary entries and simple physiological measurements. Methods In a prospective development and usability study 18 patients with migraine completed 388 headache diary entries and self-administered app-based biofeedback sessions wirelessly measuring heart rate, peripheral skin temperature and muscle tension. Several standard machine learning architectures were constructed to forecast headache the subsequent day. Models were scored with area under the receiver operating characteristics curve. Results Two-hundred-and-ninety-five days were included in the predictive modelling. The top performing model, based on random forest classification, achieved an area under the receiver operating characteristics curve of 0.62 in a hold-out partition of the dataset. Discussion In this study we demonstrate the utility of using mobile health apps and wearables combined with machine learning to forecast headache. We argue that high-dimensional modelling may greatly improve forecasting and discuss important considerations for future design of forecasting models using machine learning and mobile health data.

الإتاحة: https://doi.org/10.1177/03331024231169244Test

المؤلفون: Schoenen, Jean, Snoer, Agneta Henriette, Brandt, Roemer B, Fronczek, Rolf, Wei, Diana Y, Chung, Chin-Sang, Diener, Hans-Christoph, Dodick, David W, Fontaine, Denys, Goadsby, Peter J, Matharu, Manjit Singh, May, Arne, McGinley, James S, Tepper, Stewart J, Jensen, Rigmor Højland, Ferrari, Michel D, IHS Standing Committee for Clinical Trials, IHS cluster headache trial guideline subcommittee

المساهمون: Unité de Recherche sur les Céphalées

المصدر: Cephalalgia: an international journal of headache, 42 (14), 1450 - 1466 (2022-12)

مصطلحات موضوعية: Guidelines, ICHD-3, classifications, cluster headache, Humans, Headache/therapy, Controlled Clinical Trials as Topic, Cluster Headache/drug therapy, Headache, Neurology (clinical), General Medicine, Human health sciences, Neurology, Sciences de la santé humaine, Neurologie

الوصف: peer reviewed ; In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.

العلاقة: urn:issn:0333-1024; urn:issn:1468-2982; https://orbi.uliege.be/handle/2268/297312Test; info:hdl:2268/297312; scopus-id:2-s2.0-85142918615; info:pmid:36268950

الإتاحة: https://doi.org/10.1177/03331024221120266Test
https://orbi.uliege.be/handle/2268/297312Test

المؤلفون: Schoenen, Jean, Snoer, Agneta Henriette, Brandt, Roemer B, Fronczek, Rolf, Wei, Diana Y, Chung, Chin-Sang, Diener, Hans-Christoph, Dodick, David W, Fontaine, Denys, Goadsby, Peter J, Matharu, Manjit Singh, May, Arne, McGinley, James S, Tepper, Stewart J, Jensen, Rigmor Højland, Ferrari, Michel D, Jensen, Rigmor, Matharu, Manjit S, Brandt, Roemer W, Terwindt, Gisela, Tassorelli, Cristina, Ashina, Messoud, Leroux, Elizabeth, Lipton, Richard B, Pozo-Rosich, Patricia, Wang, Shuu-Jiun, Christensen, Marie Deen, Martini, Daniela, van den Hoek, Thomas

المصدر: Cephalalgia ; volume 42, issue 14, page 1450-1466 ; ISSN 0333-1024 1468-2982

مصطلحات موضوعية: Neurology (clinical), General Medicine

الوصف: In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.

الإتاحة: https://doi.org/10.1177/03331024221120266Test

المؤلفون: Lambru, Giorgio, Matharu, Manjit Singh

المصدر: Neurological Sciences ; volume 35, issue S1, page 77-81 ; ISSN 1590-1874 1590-3478

مصطلحات موضوعية: Psychiatry and Mental health, Neurology (clinical), Dermatology, General Medicine

الإتاحة: https://doi.org/10.1007/s10072-014-1748-yTest